美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Wuxi Biologics (Cayman) Inc

3.63

0.0000

成交量：- -

成交額：- -

市值：149.00億

市盈率：33.77

高：3.63

開：3.63

低：3.63

收：3.63

資料載入中...

總覽公司新聞公告

藥明系收入最高的5人

生物药大时代

中證香港100醫藥衞生指數報1063.69點，前十大權重包含藥明生物等

美國OTC市場藥明生物股價拉昇12.73% 市值漲18.7億美元

藥明生物7月10日成交額為129.00美元

藥明生物取得評估抗原沉默效應對抗體藥效影響方法及應用專利

藥明生物7月9日成交額為1394.00美元

生物藥產業合力突圍：一款新型長效激素的本土化落地樣本

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/WXIBF/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"WXIBF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WXIBF\",,,,,undefined,":{"symbol":"WXIBF","market":"US","secType":"STK","nameCN":"Wuxi Biologics (Cayman) Inc","latestPrice":3.63,"timestamp":1753214400000,"preClose":3.63,"halted":0,"volume":0,"delay":15,"floatShares":3505111406,"shares":4104593915,"eps":0.107499,"marketStatus":"盤後交易","change":0,"latestTime":"07-22 16:00:00 EDT 延時","open":3.63,"high":3.63,"low":3.63,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.107499,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1753228800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":3.63,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"WXIBF\",,,,,undefined,":{"symbol":"WXIBF","floatShares":3505111406,"roa":"5.05%","roe":"8.82%","lyrEps":0.112637,"shares":4104593915,"dividePrice":0,"high":3.63,"amplitude":0,"preClose":3.63,"low":3.63,"week52Low":1.3,"pbRate":"2.56","psRate":"5.72","week52High":3.7,"institutionHeld":0,"latestPrice":3.63,"eps":0.107499,"divideRate":0,"volume":0,"delay":15,"ttmEps":0.107499,"open":3.63,"prevYearClose":2.17,"prevWeekClose":3.63,"prevMonthClose":3.18,"prevQuarterClose":3.18,"fiveDayClose":3.22,"twentyDayClose":3.25,"sixtyDayClose":2.74},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"WXIBF\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2553405952","title":"藥明系收入最高的5人","url":"https://stock-news.laohu8.com/highlight/detail?id=2553405952","media":"生物药大时代","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553405952?lang=zh_tw&edition=fundamental","pubTime":"2025-07-22 00:01","pubTimestamp":1753113696,"startTime":"0","endTime":"0","summary":"药明系营收净利润2024年度药明康德营收392.41亿元，同比下滑2.73%，净利润94.5亿元，同步下滑1.63%。但是药明生物以186.8亿的营收，同比增长9.63%，80亿元的净利润，同比增长12.05%。业绩高速增长，离不开管理团队的奋斗，薪酬情况如下：药明系收入最高的5个人执行董事兼首席执行官陈智胜陈智胜是药明生物毋庸置疑的一号位人物，一手从0开始打造了药明生物。药明系用高额营收证明，为顶尖人才支付溢价，是比设备投资回报率更高的生意。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722005915a45a2939&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722005915a45a2939&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","02269","02359","02268","WXIBF","603259"],"gpt_icon":0},{"id":"2553429089","title":"中證香港100醫藥衞生指數報1063.69點，前十大權重包含藥明生物等","url":"https://stock-news.laohu8.com/highlight/detail?id=2553429089","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553429089?lang=zh_tw&edition=fundamental","pubTime":"2025-07-21 15:27","pubTimestamp":1753082828,"startTime":"0","endTime":"0","summary":"金融界7月21日消息，上证指数高开高走，中证香港100医药卫生指数 报1063.69点。数据统计显示，中证香港100医药卫生指数近一个月上涨17.50%，近三个月上涨48.03%，年至今上涨83.99%。从中证香港100医药卫生指数持仓的市场板块来看，香港证券交易所占比100.00%。从中证香港100医药卫生指数持仓样本的行业来看，化学药占比55.85%、生物药品占比18.68%、制药与生物科技服务占比14.26%、医疗商业与服务占比11.21%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721153344954aa7f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721153344954aa7f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348735423.USD","BK1576","LU0359201612.USD","SG9999002463.SGD","LU0052750758.USD","LU0819121731.USD","LU0348825331.USD","LU0417516738.SGD","LU0051755006.USD","LU0456846285.SGD","LU0043850808.USD","LU1880383366.USD","BK1141","LU0856984785.SGD","LU0516422440.USD","LU0823426480.USD","LU1242518857.USD","LU2039709279.SGD","LU0181495838.USD","LU0327786744.USD","LU0326950275.SGD","LU0456827905.SGD","LU0359202008.SGD","LU0516422366.SGD","LU0516423091.SGD","LU0588546209.SGD","LU1242518931.SGD","BK1610","LU1720050803.USD","LU0516423174.USD","BK1589","LU0516422952.EUR","LU0979878070.USD","LU0140636845.USD","LU0708995583.HKD","LU0823426308.USD","LU0320764599.SGD","WXIBF","LU0039217434.USD","LU0417516902.SGD","02269","SG9999002562.SGD","LU1794554557.SGD","LU1688375341.USD","BK1521","LU0572944931.SGD","LU0307460666.USD","IE00B0JY6N72.USD"],"gpt_icon":0},{"id":"2552108493","title":"美國OTC市場藥明生物股價拉昇12.73% 市值漲18.7億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552108493","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552108493?lang=zh_tw&edition=fundamental","pubTime":"2025-07-18 21:45","pubTimestamp":1752846305,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日21时45分，美国OTC市场药明生物股票出现异动，股价大幅拉升12.73%。美国OTC市场药明生物股票所在的生物技术行业中，整体跌幅为0.04%。美国OTC市场药明生物公司简介：无锡药明康德集团是一家生物药物的合同开发和制造组织，简称“CDMO”。它成立于 2010 年，隶属于药明康德，并于 2017 年在香港联交所上市。无锡药明康德报告称，2020年收入为56亿元人民币，三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071821450595479687&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071821450595479687&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","WXIBF"],"gpt_icon":0},{"id":"2550939897","title":"藥明生物7月10日成交額為129.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550939897","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550939897?lang=zh_tw&edition=fundamental","pubTime":"2025-07-11 16:19","pubTimestamp":1752221958,"startTime":"0","endTime":"0","summary":"美东时间2025年7月10日，药明生物成交额为129.00美元，成交额较昨日减少90.75%，当日成交量为40.00股。药明生物于2025年7月10日涨0.0%，报3.22美元，该股过去5个交易日涨1.26%，年初至今涨48.39%，过去60日涨33.06%。它成立于 2010 年，隶属于药明康德，并于 2017 年在香港联交所上市。无锡药明康德报告称，2020年收入为56亿元人民币，三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711171519a6a37751&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711171519a6a37751&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","WXIBF"],"gpt_icon":0},{"id":"2550608193","title":"藥明生物取得評估抗原沉默效應對抗體藥效影響方法及應用專利","url":"https://stock-news.laohu8.com/highlight/detail?id=2550608193","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550608193?lang=zh_tw&edition=fundamental","pubTime":"2025-07-11 09:13","pubTimestamp":1752196404,"startTime":"0","endTime":"0","summary":"金融界2025年7月11日消息，国家知识产权局信息显示，上海药明生物技术有限公司取得一项名为“一种评估抗原沉默效应对抗体药效影响的方法及其应用”的专利，授权公告号CN114371282B，申请日期为2021年12月。天眼查资料显示，上海药明生物技术有限公司，成立于2015年，位于上海市，是一家以从事研究和试验发展为主的企业。企业注册资本133000万人民币。通过天眼查大数据分析，上海药明生物技术有限公司共对外投资了1家企业，参与招投标项目12次，财产线索方面有商标信息92条，专利信息234条，此外企业还拥有行政许可187个。本文源自：金融界作者：情报员","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711091605a4438947&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711091605a4438947&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0819121731.USD","BK1521","SG9999002562.SGD","LU0708995583.HKD","LU0823426480.USD","LU0979878070.USD","LU0348735423.USD","LU0052750758.USD","LU0327786744.USD","LU0359202008.SGD","LU0417516738.SGD","BK1576","LU0140636845.USD","LU0417516902.SGD","LU0588546209.SGD","WXIBF","LU0516422440.USD","BK1610","LU0051755006.USD","LU1720050803.USD","LU0348825331.USD","LU0516422952.EUR","LU0456846285.SGD","LU0516423174.USD","LU0326950275.SGD","LU0572944931.SGD","LU1242518931.SGD","LU0516423091.SGD","02269","LU0856984785.SGD","LU0456827905.SGD","LU0359201612.USD","LU0307460666.USD","IE00B0JY6N72.USD","LU0043850808.USD","LU0181495838.USD","LU2039709279.SGD","LU0823426308.USD","BK1589","BK1141","LU1688375341.USD","LU1242518857.USD","LU1794554557.SGD","LU0516422366.SGD","SG9999002463.SGD","LU0320764599.SGD","LU1880383366.USD","LU0039217434.USD"],"gpt_icon":0},{"id":"2550612648","title":"藥明生物7月9日成交額為1394.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550612648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550612648?lang=zh_tw&edition=fundamental","pubTime":"2025-07-10 16:13","pubTimestamp":1752135185,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日，药明生物成交额为1394.00美元，当日成交量为433.00股。药明生物于2025年7月9日涨1.26%，报3.22美元，该股过去5个交易日涨1.26%，年初至今涨48.39%，过去60日涨33.06%。它成立于 2010 年，隶属于药明康德，并于 2017 年在香港联交所上市。无锡药明康德报告称，2020年收入为56亿元人民币，三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710164640a44229fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710164640a44229fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXIBF","BK4121"],"gpt_icon":0},{"id":"2548513398","title":"生物藥產業合力突圍：一款新型長效激素的本土化落地樣本","url":"https://stock-news.laohu8.com/highlight/detail?id=2548513398","media":"E药经理人","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548513398?lang=zh_tw&edition=fundamental","pubTime":"2025-07-04 18:28","pubTimestamp":1751624921,"startTime":"0","endTime":"0","summary":"在生物药管线冲刺迈入“兑现期”前，如何将高技术壁垒的创新药物真正推向商业化，成为Biotech绕不开的现实大考。但当一部分Biotech挺进临床三期，站到商业化门槛时，一个现实的问题横亘在眼前：如何将创新项目合规、高效、高质量地推向规模化生产，完成从概念验证到商业化落地的完美闭环。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704183403a436c685&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704183403a436c685&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0307460666.USD","BK1521","LU0326950275.SGD","LU0819121731.USD","LU0348825331.USD","BK1610","02561","LU0181495838.USD","LU0572944931.SGD","LU0320764599.SGD","LU0823426308.USD","LU0348735423.USD","LU0856984785.SGD","LU1242518857.USD","LU1688375341.USD","LU0456846285.SGD","LU1720050803.USD","SG9999002562.SGD","LU0417516902.SGD","LU0140636845.USD","LU0327786744.USD","LU0051755006.USD","LU0417516738.SGD","BK1576","LU0359201612.USD","LU0823426480.USD","LU0052750758.USD","LU0359202008.SGD","LU0516423174.USD","LU0516422440.USD","LU0979878070.USD","LU0708995583.HKD","LU0516422952.EUR","LU2039709279.SGD","LU0039217434.USD","LU0516423091.SGD","IE00B0JY6N72.USD","LU1242518931.SGD","LU0516422366.SGD","LU1880383366.USD","LU0456827905.SGD","02269","BK1141","WXIBF","BK1589","LU0588546209.SGD","LU1794554557.SGD","SG9999002463.SGD","LU0043850808.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/WXIBF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-08-17","symbol":"WXIBF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1660708800000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2020-12-10","symbol":"WXIBF","type":"split","dateTimestamp":1607576400000,"forFactor":1,"toFactor":3,"ratio":0.333333},{"market":"US","date":"2020-11-16","symbol":"WXIBF","type":"split","dateTimestamp":1605502800000,"forFactor":1,"toFactor":3,"ratio":0.333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"WXIBF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"WXIBF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2692,"buy":0.3846,"hold":0.3462,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3846,"analysts":26,"updateTime":1743998400000}}}